Qol Holdings Co.,Ltd. [3034.T]
TOKYO, Jun 29 (Pulse News Wire) – Qol Holdings CO.,LTD. (3034.T) disclosed details regarding its significant shareholder, Medipal Holdings Corporation.
As of March 31, 2026, Medipal Holdings holds 23.1% of Qol Holdings' shares, including direct holdings of 20.2% and indirect holdings of 2.9%. Medipal Holdings is the largest shareholder of Qol Holdings with a voting rights stake of 23.1%. Both companies maintain close cooperative relations, and Qol Holdings’ subsidiaries purchase goods from Medipal Holdings under similar conditions as those with unrelated suppliers. Qol Holdings operates independently from its parent group, ensuring fair economic conditions in their transactions.
Regarding related party transactions, there were none involving Qol Holdings itself during the fiscal year ending March 31, 2026. However, Qol Holdings’ subsidiary, Mediso, conducted business with Medipal Holdings, purchasing pharmaceutical products amounting to ¥45.95 billion. The outstanding balance was ¥10.54 billion as of March 31, 2026. Mediso is a wholly-owned subsidiary of Medipal Holdings, which owns 23.1% of Qol Holdings, including 2.9% indirectly.
Transaction conditions align with those offered to non-related parties, ensuring transparency and fairness in dealings.
🟢 Confidence: High AI-translated content.